UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Scoring treatment response in patients with relapsing multiple sclerosis

Multiple sclerosis, 2013-04, Vol.19 (5), p.605-612

2013

Volltextzugriff (PDF)

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis

European journal of neurology, 2018-02, Vol.25 (2), p.215-237

2018

Volltextzugriff (PDF)

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes

Neurology, 2010-06, Vol.74 (23), p.1868-1876

2010

Volltextzugriff (PDF)

Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis

Neurology, 2010-11, Vol.75 (22), p.1988-1994

2010

Volltextzugriff (PDF)

Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach

Neurology, 2010-07, Vol.75 (4), p.302-309

2010

Volltextzugriff (PDF)

Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study

Neurology, 2011-07, Vol.77 (3), p.250-256

2011

Volltextzugriff (PDF)

Clinical activity after fingolimod cessation: disease reactivation or rebound?

European journal of neurology, 2018-10, Vol.25 (10), p.1270-1275

2018

Volltextzugriff (PDF)

Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis

Neurology, 2011-11, Vol.77 (18), p.1684-1690

2011

Volltextzugriff (PDF)

In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study

Brain (London, England : 1878), 2007-08, Vol.130 (8), p.2211-2219

2007

Volltextzugriff (PDF)

Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience

Multiple sclerosis, 2012-06, Vol.18 (6), p.835-842

2012

Volltextzugriff (PDF)

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper

Multiple sclerosis, 2012-06, Vol.18 (6), p.825-834

2012

Volltextzugriff (PDF)

Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a

Journal of neurology, 2023-04, Vol.270 (4), p.2271-2282

2023

Volltextzugriff (PDF)

Influence of aging on brain gray and white matter changes assessed by conventional, MT, and DT MRI

Neurology, 2006-02, Vol.66 (4), p.535-539

2006

Volltextzugriff (PDF)

Time to first relapse as an endpoint in multiple sclerosis clinical trials

Multiple sclerosis, 2013-04, Vol.19 (4), p.466-474

2013

Volltextzugriff (PDF)

Long‐term clinical profile of children with the low‐penetrance R92Q mutation of the TNFRSF1A gene

Arthritis & rheumatology (Hoboken, N.J.), 2011-04, Vol.63 (4), p.1141-1150

2011

Volltextzugriff (PDF)

Thalamic Damage Predicts the Evolution of Primary-Progressive Multiple Sclerosis at 5 Years

American journal of neuroradiology : AJNR, 2011-06, Vol.32 (6), p.1016-1020

2011

Volltextzugriff (PDF)

Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis

Multiple sclerosis, 2016-05, Vol.22 (6), p.782-791

2016

Volltextzugriff (PDF)

A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS

Neurology, 2009-12, Vol.73 (22), p.1842-1848

2009

Volltextzugriff (PDF)

Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes"

Neurology, 2001-08, Vol.57 (4), p.731-733

2001

Volltextzugriff (PDF)

Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants

Bone marrow transplantation (Basingstoke), 2010-02, Vol.45 (2), p.385-391

2010

Volltextzugriff (PDF)

Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years

Brain (London, England : 1878), 2006-10, Vol.129 (10), p.2628-2634

2006

Volltextzugriff (PDF)

Neurofilaments as biomarkers in neurological disorders

Nature reviews. Neurology, 2018-10, Vol.14 (10), p.577-589

2018

Volltextzugriff (PDF)

Fingolimod effect on brain volume loss independently contributes to its effect on disability

Multiple sclerosis, 2015-06, Vol.21 (7), p.916-924

2015

Volltextzugriff (PDF)

Chronic GVHD is associated with lower relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors

Bone marrow transplantation (Basingstoke), 2012-11, Vol.47 (11), p.1474-1478

2012

Volltextzugriff (PDF)

Evidence for progressive gray matter loss in patients with relapsing-remitting MS

Neurology, 2005-10, Vol.65 (7), p.1126-1128

2005

Volltextzugriff (PDF)

1 – 25 von 333

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(300)
Mit Volltextzugriff
(260)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(210)
Life Sciences & Biomedicine
(186)
Humans
(176)
Neurosciences & Neurology
(127)
Clinical Neurology
(122)
Biological And Medical Sciences
(119)
Medical Sciences
(119)
Female
(117)
Male
(115)
Adult
(112)
Neurology
(85)
Middle Aged
(84)
Magnetic Resonance Imaging
(78)
Multiple Sclerosis
(75)
Brain - Pathology
(62)
Neurosciences
(59)
Adolescent
(39)
Magnetic Resonance Imaging - Methods
(34)
Aged
(33)
Follow-Up Studies
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Scoring treatment response in patients with relapsing multiple sclerosis

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes

Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis

Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach

Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study

Clinical activity after fingolimod cessation: disease reactivation or rebound?

Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis

In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study

Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper

Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a

Influence of aging on brain gray and white matter changes assessed by conventional, MT, and DT MRI

Time to first relapse as an endpoint in multiple sclerosis clinical trials

Long‐term clinical profile of children with the low‐penetrance R92Q mutation of the TNFRSF1A gene

Thalamic Damage Predicts the Evolution of Primary-Progressive Multiple Sclerosis at 5 Years

Relevance of asymptomatic spinal MRI lesions in patients with multiple sclerosis

A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS

Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes"

Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants

Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years

Neurofilaments as biomarkers in neurological disorders

Fingolimod effect on brain volume loss independently contributes to its effect on disability

Chronic GVHD is associated with lower relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors

Evidence for progressive gray matter loss in patients with relapsing-remitting MS

Suchergebnisse filtern